Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Summary

This is a efficacy and safety study evaluating new treatment for subjects with mild to moderate Alzheimer's Disease.

Timeline

Start

2009-10

Primary completion

2010-11

Completion

2010-11

Outcome

Missed primary endpoint

paper Although the study did not meet its primary end point PMID 29854928 ↗

Publications

• Gault LM, Ritchie CW, Robieson WZ, Pritchett Y, Othman AA, Lenz RA. A phase 2 randomized, controlled trial of the alpha7 agonist ABT-126 in mild-to-moderate Alzheimer's dementia. Alzheimers Dement (N Y). 2015 Jun 23;1(1):81-90. doi: 10.1016/j.trci.2015.06.001. eCollection 2015 Jun.

Drugs

Indications